ソレイジア・ファーマ
4597
東証グロース
医薬品
ソレイジア・ファーマの決算推移
損益計算書
(単位:百万円)
2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|
売上高 | 501 | 410 | 318 | 1,310 | 454 | 559 | 1,092 | 617 |
売上原価 | N/A | N/A | N/A | 65 | 209 | 185 | 430 | 280 |
売上総利益 | N/A | N/A | N/A | 1,244 | 244 | 373 | 662 | 337 |
販管費 | N/A | N/A | N/A | 1,868 | 2,432 | 1,948 | 2,250 | 1,073 |
営業利益 | N/A | N/A | N/A | -1,762 | -4,116 | -2,419 | -2,470 | -1,139 |
営業外収益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
営業外費用 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
経常利益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別利益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別損失 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | -475 | -1,008 | -2,422 | -1,867 | -4,127 | -2,478 | -2,548 | -1,112 |
貸借対照表
(単位:百万円)
2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|
資産 | 3,704 | 6,655 | 7,728 | 7,946 | 5,775 | 3,144 | 3,134 | 2,229 |
流動資産 | N/A | N/A | N/A | 4,302 | 3,269 | 894 | 1,435 | 976 |
現金及び預金 | 1,038 | 3,370 | 4,046 | 4,116 | 2,964 | 714 | 803 | 728 |
売上債権 | N/A | N/A | N/A | 10 | 173 | 126 | 572 | 67 |
棚卸資産 | N/A | N/A | N/A | 3 | 4 | 0 | 14 | 122 |
固定資産 | N/A | N/A | N/A | 3,644 | 2,506 | 2,249 | 1,698 | 1,252 |
負債 | N/A | N/A | N/A | 1,029 | 2,123 | 556 | 472 | 354 |
流動負債 | N/A | N/A | N/A | 925 | 2,079 | 489 | 407 | 293 |
仕入債務 | N/A | N/A | N/A | 800 | 987 | 386 | 332 | 213 |
固定負債 | N/A | N/A | N/A | 103 | 43 | 67 | 64 | 61 |
純資産 | N/A | N/A | N/A | 6,917 | 3,652 | 2,587 | 2,662 | 1,875 |
利益剰余金 | N/A | N/A | N/A | 1,400 | -2,726 | -5,204 | -223 | -1,336 |
自己株式 | N/A | N/A | N/A | -70 | -70 | -70 | -70 | -69 |